Smart Immune Announces Recommended SMART101 Dose for Adult Cancer Proof-of-Concept Trials
ReSET-02 dose escalation Phase I is completed Phase II PoC randomized segment is starting No dose-limiting toxicities, no safety or tolerability issues The highest dose is to be used in